TKNO: Alpha Teknova, Inc. Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 77.56
Enterprise Value ($M) 69.15
Book Value ($M) 83.38
Book Value / Share 2.04
Price / Book 0.93
NCAV ($M) 1.38
NCAV / Share 0.03
Price / NCAV 56.04

Profitability (mra)
Return on Invested Capital (ROIC) -0.31
Return on Assets (ROA) -0.27
Return on Equity (ROE) -0.42

Liquidity (mrq)
Quick Ratio 3.92
Current Ratio 5.52

Balance Sheet (mrq) ($M)
Current Assets 38.82
Assets 120.82
Liabilities 37.44
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 36.68
Operating Income -31.20
Net Income -36.78

Cash Flow Statement (mra) ($M)
Cash From Operations -18.70
Cash from Investing -7.74
Cash from Financing 12.80

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
3 days ago 13D Telegraph Hill Partners IV, L.P. 70.80 47.21

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-07-19 78,027 283,564 27.52
2024-07-18 260,240 887,335 29.33
2024-07-17 4,268,701 11,182,936 38.17
2024-07-16 8,585 103,207 8.32

(click for more detail)

Similar Companies
TBPH – Theravance Biopharma, Inc. TCRX – TScan Therapeutics, Inc.
TENK – TenX Keane Acquisition TLPH – Talphera, Inc.
TNGX – Tango Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io